VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > System to paediatric cardiologists from around the globe.VPT

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Apr 02, 2024 7:08am

74 Views

Post# 35964451

System to paediatric cardiologists from around the globe.VPT

We are eagerly anticipating the upcoming AEPC conference in Porto next month. It promises to be an exciting opportunity to introduce the Ventripoint System to paediatric cardiologists from around the globe. We invite you to visit our team at the Ventripoint stand for an in-depth demonstration showcasing Ventripoint's remarkable cardiac MRI measurement capabilities.

Association for European Paediatric and Congenital Cardiology - AEPC